Biothera is a U.S. biotechnology company dedicated to improving immune health. We manufacture and market patented, natural ingredients for functional foods, beverages and nutritional supplements worldwide. Wellmune WGP® and our other novel beta 1,3/1,6 gluco polysaccharide ingredients are clinically proven to safely prime key immune cells that help keep the body healthy. Specifically, Wellmune WGP mobilizes neutrophils, which are the largest population of immune cells in the body and part of the body’s first line of defense.
Derived from the cell wall of a proprietary strain of baker’s yeast (Saccharomyces cerevisiae), Wellmune WGP helps increase the effectiveness of immune cells without over-stimulating the immune system. This makes Wellmune WGP an ideal ingredient for delivering year-round, not merely seasonal, immune health benefits. Peer-reviewed, published clinical research consistently demonstrates the ability of Wellmune WGP to reduce upper respiratory tract infection symptoms and improve overall health even during periods of high physical and lifestyle stress.
Wellmune WGP is the culmination of more than $300 million in research with leading university and government institutions. It is an ingredient in food, beverage and supplement products in more than 35 countries. Wellmune is Kosher, Halal, non-allergenic, GMO-free and has broad regulatory approval worldwide including GRAS status in the U.S. and novel foods approval in Europe and China. Wellmune WGP is a recipient of an IFT Innovation Award, a 2011 SupplySide West Scientific Excellence Award and a Frost & Sullivan Excellence in Research Award.